SALT LAKE CITY, Utah, July 25, 2019 /PRNewswire/ — Curza, a privately-held small-molecule drug development company focused on the discovery and development of novel therapeutics to address the …
More Curza Announces $5.25 million Investment from the Novo Holdings REPAIR Impact Fund Videos